CN Stock MarketDetailed Quotes

300016 Beijing Beilu Pharmaceutical

Watchlist
  • 6.90
  • -0.05-0.72%
Market to Open Dec 5 09:30 CST
3.39BMarket Cap-69000P/E (TTM)

About Beijing Beilu Pharmaceutical Company

The company was founded in September 1992. The company is mainly engaged in R&D, production and sales of pharmaceutical products, and is a national high-tech enterprise and the first batch of enterprises listed on the GEM. The company's main business covers the two major sectors of chemicals (including APIs) and traditional Chinese medicine. Among them, the chemical medicine sector mainly focuses on R&D, production, and sales of products such as contrast agents and hypoglycemic agents; the traditional Chinese medicine sector mainly focuses on the production and sale of products such as central nervous system, heat cleansing and detoxification, and supplements. Main products: Gadobutin Glucamine Injection, Gadobutin Injection, Gadobutyl Glucamide Injection, Iodohexanol Injection, Iodopanol Injection, Iodoxanol Injection, Glimepiride Tablets, Regaglinide Tablets, Praxol Hydrochloride Sustained-Release Tablets, Jiuwei Zhenxin Granules, Gadobentil and Excipients, Iodotrexanol, Iodopromide and Iodopanol, Jiuwei Zhenxin Granules, Golden Lotus Tablets Detox pills, gardenia golden flower pills, lung cleansing and fire suppression pills, Shenling Baishu pills, Shenling Baishu San, stomach cleansing Huanglian pills, cold and fever clearing granules, Qiongju Shangqing pills, etc. The company received honors such as the National High-tech Enterprise Certification Certificate, 100 Innovative Pilot Enterprises in Zhongguancun Science and Technology Park, Zhongguancun High-tech Enterprises, A-level Tax Credit Enterprises, and the National Torch Program. It has received honorary titles such as Zhejiang Water-Saving Enterprise, Taizhou Green Factory, and Taizhou “Waste-free Factory”. It won the “Top 500 High-tech Enterprises in China” for 2 consecutive years, the “Beijing Top 100 Private Enterprises in Social Responsibility” for the 3rd year in a row, and also won the honorary title of “Top 500 Chinese Enterprises for Rural Revitalization”.

Company Profile

Short Name-A北陆药业
Symbol-A300016
Company NameBeijing Beilu Pharmaceutical Co.,Ltd.
Listing DateOct 30, 2009
Issue Price17.86
Shares Offered17.00M share(s)
FoundedSep 5, 1992
Legal Representativexu wang
General Managerxu wang
Secretaryzehui shao
Accounting FirmGrant Thornton Certified Public Accountants (Special General Partnership)
Securities Representativezhifang sun
Legal CounselBeijing Jingtian Gongcheng Law Firm
Employees673
Phone010-62625287
Office Address7th Floor, Block A, Fenglan International Office Building, No. 32, Xizhimen North Street, Haidian District, Beijing
Zip Code100082
Registered AddressNo. 3 Shuiyuan West Road, Miyun District, Beijing
Fax010-82626933
Emailblxp@beilu.com.cn
Business License110000004222500
BusinessProduction and sale of high-volume injections, small-volume injections, tablets, granules, and APIs (gadobutyl methanol, reglidine, gadopetamide); property management of owned houses; leasing of commercial premises, leasing of office space; import and export of goods, technology import/export, agency import and export; sales of chemical products (excluding hazardous chemicals and easily manufactured drugs); operation of the following projects: traditional Chinese medicine pre-treatment, traditional Chinese medicine extraction; APIs (gadobutyl alcohol, gadobutyl glutamate, reglinide); pharmaceutical additives (glucosamine, glutamidine, reglinel); pharmaceutical additives (glucosamine, glutamidine, reglinel); pharmaceutical additives (glutamyl, gadobutyl glutamate, reglinel); pharmaceutical additives (glucobutol, glutamine glutamate, reglinel); pharmaceutical additives (glucosamine, glutamate, reglinel); pharmaceutical additives (glucobutol, glutamine glutamate, reglinel); pharmaceutical excipients (glucosamine, acetophenone); pharmaceutical additives (glucosamine amines); production of chemical products. (Market players independently select business projects and carry out business activities in accordance with the law; projects subject to approval according to law carry out business activities according to the approved content after approval by the relevant departments; they are not allowed to engage in business activities for projects prohibited or restricted by national and local industrial policies.)

Company Executives

  • Name
  • Position
  • Salary
  • WANG XU
  • Chairman, Directors, General Manager, Nomination Committee Members, Chairman of the Strategy and Development Committee
  • 1.30M
  • qing xiang
  • Directors
  • --
  • li zong
  • Directors, Deputy General Manager
  • 901.70K
  • ni ceng
  • Directors, Deputy General Manager, Chief Financial Officer
  • 687.20K
  • zehui shao
  • Directors, Board Secretary, Deputy General Manager, Member of the Strategy and Development Committee, Member of the Remuneration and Assessment Committee
  • 804.50K
  • gang cao
  • Independent Directors, Chairman of the Audit Committee, Member of the Strategy and Development Committee
  • 60.00K
  • yingdian wang
  • Independent Directors, Nomination Committee Members, Audit Committee Member, Chairman of the Remuneration and Assessment Committee
  • 60.00K
  • bin zheng
  • Independent Directors, Member of the Remuneration and Assessment Committee, Chairman of the Nomination Committee
  • 60.00K
  • zhifang sun
  • Securities Affairs Representative
  • --
  • ying yang
  • Chairman of the Supervisory Board, Employee Supervisors
  • 262.70K
  • wei jiang
  • Auditors
  • --
  • xiasi kuang
  • Deputy General Manager
  • 687.10K
  • sen li
  • Executive Deputy General Manager, Chief Operating Officer
  • 1.65M
  • linlin wang
  • Head of Internal Audit
  • --
  • genchang zheng
  • Core Technical Personnel, Employee Supervisors
  • 514.50K